Senseonics (NYSE:SENS) Shares Gap Down – Here’s What Happened

Senseonics Holdings, Inc. (NYSE:SENS)’s share price gapped down before the market opened on Monday . The stock had previously closed at $0.96, but opened at $0.84. Senseonics shares last traded at $0.90, with a volume of 5,892,521 shares.

Analysts Set New Price Targets

A number of analysts have recently weighed in on SENS shares. StockNews.com initiated coverage on shares of Senseonics in a report on Thursday, December 26th. They set a “sell” rating for the company. HC Wainwright restated a “buy” rating and set a $2.00 target price on shares of Senseonics in a research note on Friday, November 15th.

Senseonics Price Performance

The business’s fifty day moving average price is $0.60 and its 200 day moving average price is $0.45. The company has a quick ratio of 2.38, a current ratio of 2.47 and a debt-to-equity ratio of 59.17.

Senseonics (NYSE:SENS) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.03) by ($0.01). The company had revenue of $4.26 million during the quarter, compared to the consensus estimate of $4.02 million. Senseonics had a negative net margin of 362.30% and a negative return on equity of 842.25%. As a group, analysts anticipate that Senseonics Holdings, Inc. will post -0.14 EPS for the current year.

Insider Activity

In other Senseonics news, CFO Frederick T. Sullivan acquired 124,933 shares of Senseonics stock in a transaction that occurred on Thursday, December 12th. The shares were bought at an average price of $0.38 per share, with a total value of $47,474.54. Following the completion of the purchase, the chief financial officer now directly owns 2,478,844 shares in the company, valued at $941,960.72. This trade represents a 5.31 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Timothy T. Goodnow bought 315,000 shares of the stock in a transaction that occurred on Tuesday, December 10th. The shares were bought at an average cost of $0.31 per share, with a total value of $97,650.00. Following the completion of the transaction, the chief executive officer now owns 11,310,355 shares in the company, valued at $3,506,210.05. The trade was a 2.86 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 3.60% of the company’s stock.

Institutional Trading of Senseonics

Institutional investors have recently added to or reduced their stakes in the stock. Ridgecrest Wealth Partners LLC acquired a new position in shares of Senseonics in the 4th quarter worth approximately $60,000. FMR LLC raised its stake in Senseonics by 48,267.2% during the third quarter. FMR LLC now owns 168,318 shares of the company’s stock worth $59,000 after buying an additional 167,970 shares during the last quarter. GSA Capital Partners LLP acquired a new position in Senseonics in the third quarter valued at $117,000. Cubist Systematic Strategies LLC grew its holdings in Senseonics by 25.9% during the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock worth $166,000 after acquiring an additional 85,501 shares during the period. Finally, Symmetry Partners LLC bought a new position in shares of Senseonics in the 3rd quarter worth about $164,000. 12.36% of the stock is currently owned by institutional investors.

About Senseonics

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.